Chippenham, UK – 5 September 2016: Vectura Group plc (LSE: VEC) ("Vectura"), an industry-leading inhaled airways disease focused business, confirms the announcement by our alliance partner Novartis that new analyses from the head-to-head FLAME study confirmed that Ultibro® Breezhaler® is a more effective option for patients at risk of chronic obstructive pulmonary disease (COPD) flare-ups (exacerbations) than Seretide®, across different patient sub-groups1-10. These findings are being presented at the 2016 European Respiratory Society (ERS) International Congress this week in London, UK.
Joseph Bennington-Castro is a Hawaii-based contributing writer for Live Science and . He holds a master's degree in science journalism from New York University, and a bachelor's degree in physics from the University of Hawaii. His work covers all areas of science, from the quirky mating behaviors of different animals, to the drug and alcohol habits of ancient cultures, to new advances in solar cell technology. On a more personal note, Joseph has had a near-obsession with video games for as long as he can remember, and is probably playing a game at this very moment.
Riddle me this? How do two doctors send a diabetic home with steriods for an undisclosed condtion? And never did they mention and changes I might need to be aware of, being a diabetic. Not to menation, the fact that they couldn’t figure out or even consider psorisis now that I have learned more about it, it’s pretty common. I’m not a doctor and I wasn’t aware of this disease. What I have become aware of, is if you catch it early you can take steps to minimize the breakout hence pain. I’m considering taking further action.